Global vaccine rollout hikes BioNTech profit

By Agence France-Presse

Mar 31, 2022 12:08 am

FRANKFURT, Germany: German vaccine maker BioNTech on Wednesday reported a multibillion-euro windfall in 2021 from sales of its anti-coronavirus jab, developed together with United States pharmaceutical giant Pfizer.

Mainz-based BioNTech made a net income of 10.3 billion euros ($11.5 billion) last year, up from 15 million euros in 2020, the first year of the Covid-19 pandemic.

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

Laggard European markets may be 2025's top recovery

Bank Indonesia to hold rates this month

Bitcoin surges to record $106,000

China's Instagram-like Xiaohongshu making inroads

Chinese firms take on EV truck challenges

Foreign-born CEO says Japan needs immigration

China's CNOOC sells US assets to INEOS